Exciting Phase 2 results with ensifentrine dry powder inhaler formulation
Runtime: 06:23
Ensifentrine offers potential benefits to COPD sufferers Verona Pharma CEO Jan-Anders Karlsson tells Proactive.
Living with COPD: I can't breathe
COPD: Limited treatment options
Verona Pharma plc
3 More London Riverside,
London SE1 2RE
T: +44 (0)203 283 4200
E: info@veronapharma.com
© Verona Pharma plc 2019
